Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Thyroid Neoplasms × Digoxin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Endocrine 1

Conditions

Breast Neoplasms 3 Pancreatic Neoplasms 2 Melanoma 2 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Prostatic Neoplasms 1 Neoplastic Cells, Circulating 1 Myelodysplastic Syndromes 1 Leukemia, Myeloid, Acute 1 Head and Neck Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Advanced Pancreatic Cancer 1

Interventions

Iodine-131 14 trametinib 8 dabrafenib 8 Thyroxine 8 Thyroidectomy 8 Surgical Procedures, Operative 8 Magnetic Resonance Spectroscopy 8 lenvatinib 6 anlotinib 6 Paclitaxel 6 pembrolizumab 5 Thyrotropin Alfa 5 Saline Solution 5 Everolimus 5 selpercatinib 4 pazopanib 4 Vemurafenib 4 Sunitinib 4 Sorafenib 4 Radiofrequency Ablation 4 Nivolumab 4 Fluorodeoxyglucose F18 4 Dexmedetomidine 4 Cyclophosphamide 4 Biopsy, Fine-Needle 4 Biopsy 4 apatinib 3 Triiodothyronine 3 Transurethral Resection of Prostate 3 Sirolimus 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05507775 2024-04-11

DIGUP-TC

Radboud University Medical Center

Phase NA Completed

EndocrineHead & Neck

Thyroid Cancer, Papillary, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡